Health Canada has issued a warning about an increased risk of adverse events and decreased risk of overall survival associated with Gilead Sciences’ blood cancer medication Zydelig (generic: idelalisib).
Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Zydelig side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
May 3, 2016 – Decreased overall survival and increased rates of adverse events have been observed in patients treated with Zydelig compared to control groups in Phase III studies investigating the drug for first-line treatment of chronic lymphocytic leukemia (CLL) and early lines of relapsed indolent non-Hodgkin’s lymphoma (iNHL). Most of the adverse events reported were infections such as sepsis and pneumonia.
In March, 4 Canadian trials involving Zydelig in combination with other cancer drugs were halted, along with other international clinical trials involving the medication, following reports of “an increased rate of serious adverse events, including deaths.”
The same month, the European Medicines Agency (EMA) announced that its Pharmacovigilance Risk Assessment Committee (PRAC) would be issuing provisional advice for physicians and patients to ensure that Zydelig would continue to be used as safely as possible, and the U.S. Food and Drug Administration (FDA) began investigating the issue.
Do I Have a Zydelig Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zydelig lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
Free Confidential Case Evaluation: Again, if you were injured by Zydelig, or if a loved one died after being treated with the medication, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.